^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    TeloViewSMM test

    Company:
    Telogenomics
    Type:
    Laboratory Developed Test
    Details
    Evidence

    News

    29d
    Telo Genomics receives approval from the Intellectual Property Ontario Program (IPON) (Newsfile Corp)
    "Telo Genomics Corp...is pleased to announce that its application to the IPON program (Intellectual Property Ontario) was approved...The most recent patent applications filed by Telo support intellectual property protection of its flagship product for smoldering multiple myeloma TeloViewSMM."
    Patent
    |
    TeloViewSMM test
    6ms
    Telo Genomics announces its TeloViewSMM Test is accepted as laboratory developed test by CAP (BioSpace)
    "Telo Genomics Corp...is pleased to announce that the College of American Pathologists (CAP) has recently accepted Telo Genomics’ submission to add Telo’s test for smoldering multiple myeloma (SMM), TeloViewSMM, as a Laboratory Developed Test (LDT) on Telo’s-CAP approved menu of clinical tests."
    Approval
    |
    TeloViewSMM test